E. coli is primarily used for prokaryotic antibody expression due to its limited glycosylation, folding, and secretion capabilities. Several strategies have been used to improve folding efficiency in E. coli, including overexpressing chaperones, growing at low temperatures, and using osmolytes and alcohols. High cell density fermentation in bioreactors leads to much higher antibody yields, up to 1.2 g/L, compared to shake flask production which yields only 16.5 mg/L for the same antibody. Creative Biolabs has developed a novel prokaryotic antibody production service using their magicTM platform.